The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing of shares in Plutus Powergen plc

1 Dec 2015 11:22

RNS Number : 5558H
Paternoster Resources PLC
01 December 2015
 

1 December 2015

 

Paternoster Resources plc

 

("Paternoster" or the "Company")

 

Placing of shares in Plutus Powergen plc

 

Paternoster is pleased to announce the sale of 25 million shares in Plutus Powergen plc ("Plutus") at a price of 1.1 pence per share for a total consideration of £275,000 before expenses. This represents a 4.4x return on Paternoster's original investment made at the time when Paternoster was involved in the establishment of the precursor company to Plutus. Also, the proceeds from just this sale alone exceed the cost of the Company's entire investment in Plutus. Paternoster will continue to hold 69.3 million shares in Plutus or 12.1%, of which 20 million shares are subject to an option in favour of certain members of the Plutus management team at a price of 0.6 pence per share.

 

Nicholas Lee, Chairman said:

 

"We continue to believe that Plutus has an interesting and exciting business model. However, notwithstanding this, it is only prudent for an investment company such as Paternoster to realise an element of the substantial gain that it has made from this investment. At the same time, it has retained a good-sized shareholding in the company in order to benefit from its envisaged future development. It is also important to demonstrate to our investors, that the Company can realise the profit created within its investment portfolio which this transaction clearly does.

 

As we have previously remarked, we are continuing to see some very attractive investment opportunities, and are currently involved in a number of interesting discussions. Investors with cash can, in today's market, make very attractive partners and so this realisation, together with our recent placing, puts us in a very good position to take advantage of these opportunities".

 

For more information please contact:

Paternoster Resources plc:

Nicholas Lee, Chairman

Matt Lofgran, Non-Executive Director

+44 20 7580 7576

+1 480 993 8933

 

Nominated Advisor and Joint Broker:

Westhouse Securities

Antonio Bossi/David Coaten

+44 20 7601 6100

 

Joint Broker:

Peterhouse Corporate Finance

Lucy Williams

+44 20 7562 3351

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBBBDDGDGBGUB
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.